Innovations in diagnostic technologies enhance precision medicine and research capabilities. Bionano Genomics reported advancements in optical genome mapping software with AI-driven variant interpretation and improved structural variation detection, although revenues declined slightly in Q2 2025. Cut&Tag assay modifications enable improved detection of transient transcription factor binding, boosting epigenetics research resolution. Additionally, new portable molecular point-of-care devices aim to combine accuracy and accessibility for infectious disease screening in low-resource settings, demonstrating progress toward decentralized diagnostics.